Literature DB >> 34504726

Klinefelter's Syndrome with Maternal Uniparental Disomy X, Interstitial Xp22.31 Deletion, X-linked Ichthyosis, and Severe Central Nervous System Regression.

Jennifer Brault1,2, Laurence Walsh3,4,5, Gail H Vance3, David D Weaver3.   

Abstract

We presented in this article a patient with Klinefelter syndrome (KS) (47,XXY) who had maternal nondisjunction and uniparental disomy of the X chromosome with regions of heterodisomy and isodisomy, an interstitial Xp22.31 deletion of both X chromosomes, and other problems. His mother also possesses the same Xp22.31 deletion. The patient presented with status epilepticus and stroke, followed by severe brain atrophy and developmental regression. His unusual clinical and cytogenetic findings apparently have not been reported with either KS or Xp22.31 deletions. Based on the patient's available genetic and biochemical information, we cannot satisfactorily explain his seizures, strokes, or catastrophic brain regression. Thieme. All rights reserved.

Entities:  

Keywords:  Klinefelter syndrome; X-linked ichthyosis; interstitial Xp22.3 deletion; maternal nondisjunction; status epilepticus; stroke; uniparental disomy

Year:  2020        PMID: 34504726      PMCID: PMC8416204          DOI: 10.1055/s-0040-1715573

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  27 in total

1.  Interstitial deletion in Xp22.3 is associated with X linked ichthyosis, mental retardation, and epilepsy.

Authors:  B C Gohlke; K Haug; M Fukami; W Friedl; M Noeker; G A Rappold; F Haverkamp
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

2.  Case report of Klinefelter's syndrome with severe diabetes, dyslipidemia, and stroke: The effect of pioglitazone and other anti-inflammatory agents on interleukin-6 and -8, tumor necrosis factor-alpha, and C-reactive protein.

Authors:  Issei Yoshiuchi; Naoto Itoh; Misa Nakano; Chikao Tatsumi; Kenji Yokoyama; Tatsuo Matsuyama
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  The natural history of Klinefelter's syndrome.

Authors:  M L Barr
Journal:  Fertil Steril       Date:  1966 Jul-Aug       Impact factor: 7.329

4.  Clinical neuroimaging features and outcome in molybdenum cofactor deficiency.

Authors:  Kayal Vijayakumar; Rox Gunny; Stephanie Grunewald; Lucinda Carr; Kling W Chong; Catherine DeVile; Robert Robinson; Niamh McSweeney; Prab Prabhakar
Journal:  Pediatr Neurol       Date:  2011-10       Impact factor: 3.372

5.  Seizures in Klinefelter's syndrome: a clinical and EEG study of five patients.

Authors:  M Elia; S A Musumeci; R Ferri; C Scuderi; S Del Gracco; M C Stefanini
Journal:  Ital J Neurol Sci       Date:  1995-05

6.  Evidence of the high prevalence of neurological disorders in nonsyndromic X-linked recessive ichthyosis: a retrospective case series.

Authors:  B Rodrigo-Nicolás; E Bueno-Martínez; A Martín-Santiago; J Cañueto; A Vicente; A Torrelo; L Noguera-Morel; A Duat-Rodríguez; C Jorge-Finnigan; I Palacios-Álvarez; J L García-Hernández; D F Sebaratnam; R González-Sarmiento; A Hernández-Martín
Journal:  Br J Dermatol       Date:  2018-09-11       Impact factor: 9.302

7.  Conventional and molecular cytogenetic identification of a variant klinefelter syndrome patient with a deleted X chromosome.

Authors:  H F Mark; D Feldman; M Sigman
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

8.  The origin of 47,XXY and 47,XXX aneuploidy: heterogeneous mechanisms and role of aberrant recombination.

Authors:  M MacDonald; T Hassold; J Harvey; L H Wang; N E Morton; P Jacobs
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

9.  Assignment by deletion mapping of the steroid sulfatase X-linked ichthyosis locus to Xp223.

Authors:  L Tiepolo; O Zuffardi; M Fraccaro; D di Natale; L Gargantini; C R Müller; H H Ropers
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

10.  Behavioural and psychiatric phenotypes in female carriers of genetic mutations associated with X-linked ichthyosis.

Authors:  Alice Cavenagh; Sohini Chatterjee; William Davies
Journal:  PLoS One       Date:  2019-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.